| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Other current assets | - | - | 20,000 | |
| Total current assets | 43,468,364 | 3,960,673 | 2,845,538 | |
| Other assets | 2,000 | 2,000 | 2,000 | |
| Total assets | 43,470,364 | 3,962,673 | 2,847,538 | |
| Total stockholders equity | - | - | 33,134 | |
| Total stockholders equity (deficit) | 38,547,078 | -1,652,283 | - | |
| Total liabilities & stockholders equity (deficit) | 43,470,364 | 3,962,673 | 2,847,538 | |
Qualigen Therapeutics, Inc. (QLGN)
Qualigen Therapeutics, Inc. (QLGN)